The Power of Communication and Being A Non-Specialist

CPSA Everyday Conversation

Darragh Murnane, University of Hertfordshire

“How can we communicate better so that they (patients) can go on with their life.” – Darragh Murnane, University of Hertfordshire

Darragh discusses the importance of communication in the sciences and to non-experts.  During the period of lockdown, Darragh noticed how difficult it is to navigate risk with disease, specifically how his parents were accessing health risks during the pandemic.  Across the board, how do we improve communication and education for all patients?  Darragh proposes education in communication skills early during a specialist career – ultimately helping the educate the patient, creating an improved situation, and creating a therapy, not just a treatment.

Conducting Inpatient Clinical Research During a Pandemic

23rd Annual Symposium on Clinical & Pharmaceutical Solutions through Analysis (CPSA USA 2020)

Mary Ann Diliberto, The Children’s Hospital of Philadelphia

“We need to find better ways to connect to get work done.” – Mary Ann Diliberto, The Children’s Hospital of Philadelphia

Marry Ann Diliberto describes many of the challenges for clinical research since the onset of the pandemic.  During March 2020, all clinical research stopped, creating difficulties for patients and important studies.  In Mary’s group, they had over 25 studies, managed by 15 staff members – all had to be shut down.  She describes the feeling and thoughts during the onset of the pandemic:  When can we resume research safely and efficiently?  We need to be helping these patients.  We need to be able to see the patients!  After these initial challenging times, Mary and her teams have worked together to implement new protocols and systems, within the reality of the new normal.

Patient Centricity: Why Not Use Microsampling Now?

CPSA Everyday Conversation

Matthew Barfield, Roche

“Giving control back to the patient is going the change everything.” – Matthew Barfield, Roche

Matt Barfield discusses his passions that drive him everyday – in life and research.  He looks to help his family, and everyone’s families, while advancing patient centric medicine, alleviating suffering and pain.  Matt also wants to help deliver faster results for drug discovery – where sometimes the drug does not pass phase III.  He understands clinical trials and looks to break through the mistrust of families, changing the paradigm of how we sample.  Smaller samples are less uncomfortable and less painful, especially for children with diseases like Duchenne’s Muscular Dystrophy.  Instead of hiding behind barriers that don’t exist, why not use micro sampling now?